Sign In
Buy RDNT
RadNet Earnings Calls
| Release date | May 11, 2026 |
| EPS estimate | -$0.140 |
| EPS actual | -$0.280 |
| EPS Surprise | -100.00% |
| Revenue estimate | 557.932M |
| Revenue actual | 575.6M |
| Revenue Surprise | 3.17% |
| Release date | Mar 02, 2026 |
| EPS estimate | $0.190 |
| EPS actual | $0.230 |
| EPS Surprise | 21.05% |
| Revenue estimate | 516.685M |
| Revenue actual | 547.712M |
| Revenue Surprise | 6.00% |
| Release date | Nov 09, 2025 |
| EPS estimate | $0.223 |
| EPS actual | $0.200 |
| EPS Surprise | -10.27% |
| Revenue estimate | 494.481M |
| Revenue actual | 522.869M |
| Revenue Surprise | 5.74% |
| Release date | Aug 10, 2025 |
| EPS estimate | $0.170 |
| EPS actual | $0.310 |
| EPS Surprise | 82.35% |
| Revenue estimate | 493.521M |
| Revenue actual | 498.23M |
| Revenue Surprise | 0.95% |
Last 4 Quarters for RadNet
Below you can see how RDNT performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 10, 2025 |
| Price on release | $53.36 |
| EPS estimate | $0.170 |
| EPS actual | $0.310 |
| EPS surprise | 82.35% |
| Date | Price |
|---|---|
| Aug 04, 2025 | $55.77 |
| Aug 05, 2025 | $55.46 |
| Aug 06, 2025 | $52.96 |
| Aug 07, 2025 | $52.53 |
| Aug 08, 2025 | $53.36 |
| Aug 11, 2025 | $62.00 |
| Aug 12, 2025 | $63.60 |
| Aug 13, 2025 | $68.41 |
| Aug 14, 2025 | $68.75 |
| 4 days before | -4.32% |
| 4 days after | 28.84% |
| On release day | 16.19% |
| Change in period | 23.27% |
| Release date | Nov 09, 2025 |
| Price on release | $78.31 |
| EPS estimate | $0.223 |
| EPS actual | $0.200 |
| EPS surprise | -10.27% |
| Date | Price |
|---|---|
| Nov 03, 2025 | $77.82 |
| Nov 04, 2025 | $78.49 |
| Nov 05, 2025 | $78.13 |
| Nov 06, 2025 | $78.91 |
| Nov 07, 2025 | $78.31 |
| Nov 10, 2025 | $80.85 |
| Nov 11, 2025 | $78.50 |
| Nov 12, 2025 | $74.45 |
| Nov 13, 2025 | $73.46 |
| 4 days before | 0.630% |
| 4 days after | -6.19% |
| On release day | 3.24% |
| Change in period | -5.60% |
| Release date | Mar 02, 2026 |
| Price on release | $75.22 |
| EPS estimate | $0.190 |
| EPS actual | $0.230 |
| EPS surprise | 21.05% |
| Date | Price |
|---|---|
| Feb 24, 2026 | $67.79 |
| Feb 25, 2026 | $70.01 |
| Feb 26, 2026 | $72.09 |
| Feb 27, 2026 | $69.81 |
| Mar 02, 2026 | $75.22 |
| Mar 03, 2026 | $72.58 |
| Mar 04, 2026 | $71.33 |
| Mar 05, 2026 | $66.67 |
| Mar 06, 2026 | $60.68 |
| 4 days before | 10.96% |
| 4 days after | -19.33% |
| On release day | -3.51% |
| Change in period | -10.49% |
| Release date | May 11, 2026 |
| Price on release | $55.90 |
| EPS estimate | -$0.140 |
| EPS actual | -$0.280 |
| EPS surprise | -100.00% |
| Date | Price |
|---|---|
| May 05, 2026 | $59.02 |
| May 06, 2026 | $58.64 |
| May 07, 2026 | $57.50 |
| May 08, 2026 | $58.19 |
| May 11, 2026 | $55.90 |
| May 12, 2026 | $56.00 |
| May 13, 2026 | $52.98 |
| May 14, 2026 | $53.43 |
| May 15, 2026 | $52.39 |
| 4 days before | -5.29% |
| 4 days after | -6.28% |
| On release day | 0.179% |
| Change in period | -11.23% |
RadNet Earnings Call Transcript Summary of Q1 2026
RadNet reported record first-quarter 2026 revenue and adjusted EBITDA despite estimated weather-related headwinds (~$13M revenue, ~$9M adjusted EBITDA). Total company revenue rose 22.1% year-over-year and adjusted EBITDA increased 36.3%, with adjusted EBITDA margin improvement (+115 bps reported; +52 bps when normalizing weather/wildfire impacts). Key operational drivers were strong same-center advanced-imaging growth (advanced imaging mix up to 29.3% of procedures; same-center MRI growth in high single digits; PET/CT +35% aggregate, +14.7% same-center), productivity gains from Digital Health deployments (TechLive remote scanning, AI-driven workflows) and continued contribution from acquisitions and de novos. Digital Health (DeepHealth) momentum: Q1 ARR reached $97M (95% YoY growth), with a pipeline >$150M total contract value and a target >$140M ARR by year-end; Gleamer acquisition (France) closed and integration has begun. RadNet raised 2026 full-year guidance for imaging center revenue (+$30M at both ends), adjusted EBITDA (+$5M) and free cash flow (+$7M) based on stronger-than-expected March–April performance. Liquidity remains strong ($455M cash; full $282M revolver available); net debt to adjusted EBITDA ~2.0x. Days sales outstanding improved to a company record ~29.5 days due to collections and revenue-cycle initiatives. The company reiterated Digital Health full-year guidance (Revenue $135M–$145M; adjusted EBITDA $10M–$12M) and characterizes current Digital Health margins as intentionally reduced near-term due to acquisitions and investments while organic core margins are materially higher. RadNet continues to expand via acquisitions and health-system joint ventures (recent 51% JV interest with Saint Alphonsus/Trinity Health in Boise), and management emphasized the strategic shift toward an enterprise, cloud-native AI-enabled radiology workflow to drive throughput, quality and monetization (including potential T-code reimbursements).
